Blog

Media

Potentially promising Alzheimer’s drug going forward

A drug created by the company Biogen might be able to slow the progression of Alzheimer’s Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer’s Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

Related Posts

For Immediate Release Ottawa, ON – September 20, 2023 – The Dementia Society of Ottawa and Renfrew County will be hosting the BrainyActive Walk for[...]
Article
Real-life learning or clinical experience is difficult to get as we emerge from the  pandemic. Many healthcare environments are still operating at reduced levels or under restrictive[...]
Article
At The Dementia Society, we know that knowledge about brain health and dementia play a crucial role to reduce risks and prevent some forms of[...]
Article
Did you know that one in five Canadians experiences caregiving for someone living with dementia? Numbers also suggest that one in five of those caregivers[...]
Article
The Covid-19 pandemic has been a time of confusion and conflict across the world. While some of us tried every recipe in the book and[...]
Article
Are brain health and wellness indicators of gender equality?  Canadian women live about five years longer than men. This fact has often been used to[...]